CME Group Inc. $CME is London & Capital Asset Management Ltd’s 8th Largest Position

London & Capital Asset Management Ltd boosted its holdings in CME Group Inc. (NASDAQ:CME) by 41.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 191,469 shares of the financial services provider’s stock after purchasing an additional 56,259 shares during the quarter. CME Group makes up 3.7% of London & Capital Asset Management Ltd’s portfolio, making the stock its 8th biggest holding. London & Capital Asset Management Ltd owned approximately 0.05% of CME Group worth $51,731,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the business. Empowered Funds LLC lifted its holdings in shares of CME Group by 11.5% during the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock worth $2,660,000 after acquiring an additional 1,037 shares during the period. Arkadios Wealth Advisors grew its holdings in CME Group by 43.1% in the second quarter. Arkadios Wealth Advisors now owns 3,159 shares of the financial services provider’s stock valued at $871,000 after purchasing an additional 951 shares during the period. Hantz Financial Services Inc. increased its position in CME Group by 83.8% during the second quarter. Hantz Financial Services Inc. now owns 329 shares of the financial services provider’s stock worth $91,000 after purchasing an additional 150 shares during the last quarter. HBK Sorce Advisory LLC increased its position in CME Group by 38.9% during the second quarter. HBK Sorce Advisory LLC now owns 1,190 shares of the financial services provider’s stock worth $328,000 after purchasing an additional 333 shares during the last quarter. Finally, Assetmark Inc. raised its stake in CME Group by 36.1% during the second quarter. Assetmark Inc. now owns 34,144 shares of the financial services provider’s stock worth $9,411,000 after purchasing an additional 9,063 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME reported record 2025 results: $6.5B in revenue, AD volume rose 6% to 28.1M contracts (commodities +12%, financials +5%), highlighting continued franchise growth and fee-related revenue strength. This earnings strength is the primary bullish catalyst. CME Group (CME) Achieves Record 2025 Results with $6.5B in Revenue
• Positive Sentiment: CME expanded physical-market infrastructure by approving the first aluminium warehousing facility in Taiwan, supporting commodities product growth and global market access for metals. That strengthens long-term fees and product diversification. CME approves first aluminium warehousing in Taiwan
• Neutral Sentiment: Intraday data and flow reports show mixed signals: QuiverQuant flagged heavy volume and both insider selling and sizable institutional position changes (some managers added, some trimmed). This suggests active rebalancing rather than a clear directional bet. $CME stock is up 2% today. Here’s what we see in our data.
• Neutral Sentiment: Reported short-interest data in the feed appears anomalous (zeros/NaN). No clear short-pressure signal is evident from that entry, so it shouldn’t be driving meaningful price moves. (Treat as data glitch/unreliable.)
• Negative Sentiment: CME experienced a brief technical glitch that halted metals and natural gas trading on Globex and briefly pressured the stock when markets reacted; trading was subsequently restarted. Operational reliability concerns can weigh on near-term sentiment until fully resolved. CME Group halts metals and natural gas trading on technical issues
• Negative Sentiment: Commentary criticizing CME’s Variable Storage Rate program (commodity storage economics) may pressure sentiment among some commodities market participants; impact is likely niche but could attract headlines. Why I Hate Variable Storage Rates

CME Group Stock Up 1.0%

Shares of NASDAQ CME opened at $319.50 on Monday. CME Group Inc. has a 12-month low of $248.53 and a 12-month high of $322.57. The company has a market cap of $115.21 billion, a P/E ratio of 28.63, a P/E/G ratio of 3.74 and a beta of 0.27. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.12. The stock has a fifty day moving average price of $287.63 and a 200 day moving average price of $275.99.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 EPS for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same quarter in the previous year, the firm posted $2.52 earnings per share. The firm’s quarterly revenue was up 8.1% on a year-over-year basis. Research analysts anticipate that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Shareholders of record on Tuesday, March 10th will be issued a $1.30 dividend. The ex-dividend date is Tuesday, March 10th. This represents a $5.20 dividend on an annualized basis and a yield of 1.6%. This is a boost from CME Group’s previous quarterly dividend of $1.25. CME Group’s dividend payout ratio (DPR) is currently 46.59%.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on CME shares. Weiss Ratings reissued a “buy (b+)” rating on shares of CME Group in a research note on Monday, December 29th. Raymond James Financial reduced their target price on CME Group from $311.00 to $310.00 and set an “outperform” rating on the stock in a report on Wednesday, February 4th. UBS Group reissued a “neutral” rating and set a $310.00 price target on shares of CME Group in a research report on Friday, February 6th. The Goldman Sachs Group upped their price target on CME Group from $264.00 to $266.00 and gave the stock a “sell” rating in a research note on Monday, February 9th. Finally, Rothschild & Co Redburn raised their price objective on CME Group from $300.00 to $333.00 and gave the stock a “neutral” rating in a report on Thursday, February 12th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $299.53.

Insider Buying and Selling

In other CME Group news, Director Martin J. Gepsman sold 300 shares of the stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $305.90, for a total value of $91,770.00. Following the completion of the sale, the director owned 24,999 shares of the company’s stock, valued at $7,647,194.10. This trade represents a 1.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Bryan T. Durkin sold 4,200 shares of the business’s stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the transaction, the director directly owned 43,007 shares in the company, valued at approximately $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 30,248 shares of company stock valued at $8,355,450 over the last three months. Company insiders own 0.30% of the company’s stock.

CME Group Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.